Drugs / BAP5191
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05848453 | Mar 2023 → Mar 2024 | — | Bacoba AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAP5191 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05848453 ↗ |
| Route | Topical | “receive BAP5191 and placebo topically” NCT05848453 ↗ |